AMRI and HarkerBIO to Partner on Drug Discovery
Monday, June 1, 2015
Source: The Buffalo News
Albany Molecular Research Inc., a drug discovery company that has moved into a new facility on the Buffalo Niagara Medical Campus, and HarkerBIO, a Buffalo-based startup company, have reached a collaborative, three-year agreement to jointly market their services to international pharmaceutical and biotech firms, the companies announced Monday.
Under the agreement, AMRI gains access to HarkerBIO technology that helps companies better understand the three-dimensional structures of diseases, while HarkerBIO’s customers benefit from AMRI’s global reach and its integrated drug-discovery platforms. Financial terms of the agreement were not disclosed.